Galanis, A., Ma, H., Rajkhowa, T., Ramachandran, A., Small, D., Cortes, J., & Levis, M. (2014). Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants. American Society of Hematology.

Galanis, Allison, Hayley Ma, Trivikram Rajkhowa, Abhijit Ramachandran, Donald Small, Jorge Cortes, và Mark Levis. Crenolanib Is a Potent Inhibitor of FLT3 With Activity against Resistance-conferring Point Mutants. American Society of Hematology, 2014.

Galanis, Allison, et al. Crenolanib Is a Potent Inhibitor of FLT3 With Activity against Resistance-conferring Point Mutants. American Society of Hematology, 2014.